The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...
Everyday Health on MSN
What to expect when using a GLP-1 for MASH
Learn more about what to expect if you’ve been prescribed this weight loss medication to help treat this chronic liver condition.
Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...
6don MSN
Novo introduces Ozempic in India: How the new GLP-1 option works for difficult-to-control diabetes
CHENNAI: Novo Nordisk has introduced Ozempic, its once-weekly injectable semaglutide, to the Indian market on Friday.
Ozempic is finally here — but it doesn’t come cheap. With costs touching ₹11,000 a month and generics still a year away, here ...
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs ...
Blockbuster semaglutide injection offered in weekly FlexTouch pens; firm says pricing kept ‘competitive’ for India ...
Ozempic, the popular diabetes and weight-loss drug, launches in India starting at ₹8,800. Here are the prices, dosage options ...
Novo Nordisk launches Ozempic in India, a type 2 diabetes treatment with weight-loss benefits, starting at ₹2,200 per week.
Outlook Business on MSN
Novo Nordisk Launches Ozempic in India Amid Fight With Local Pharma Cos
The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs ...
Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results